Business ❯ Healthcare

Pharmaceutical Companies

Eli Lilly Clinical Trials Stock Market Nectar Lifesciences Market Reactions Market Competition Clinical Research Pricing Strategies Novo Nordisk GSK Sanofi

Eli Lilly Becomes First Health Care Company Valued at $1 Trillion

Soaring GLP‑1 sales, plus expectations for an oral obesity pill, lifted the drugmaker to the milestone.

Jasper Therapeutics Investors Face Lead Plaintiff Deadline in Securities Class Action

Trump Pledges Sharp Cuts to GLP-1 Drug Prices as Novo, Lilly Shares Slide

Metsera’s Obesity Drug Posts 14% Placebo-Adjusted Weight Loss, Bolstering Pfizer Buyout Case